Group Pharmaceuticals Limited

Group Pharmaceuticals Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH1980PLC022889 Incorporated 24 July 1980 ROC Mumbai HQ Thane, Maharashtra, India
Active Public Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹168.31 Cr
▲ 10% YoY
Net profit · FY 2025
₹10.44 Cr
Net margin 6.2%
EBITDA · FY 2025
₹15.78 Cr
EBITDA margin 9.4%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹12.68 Cr
Issued & subscribed
Open charges
₹20 Cr
Satisfied ₹31.62 Cr
Company age
46 yrs
Est. 1980
Employees · EPFO
739
Provident fund records

About Group Pharmaceuticals Limited

Data last updated:

Group Pharmaceuticals Limited is a public limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 July 1980 and has been in existence for over 46 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1980PLC022889. Its GSTIN is 27AAACG8723H1ZK (Maharashtra). The company holds 12 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹12.68 Cr. It was formerly known as Group Pharmaceuticals Private Limited. It is led by directors including Deepak Mohan (Managing Director) and Ann Valerie Sunil Attavar (Whole-Time Director).

Its last annual general meeting (AGM) was held on 26 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at W – 46 (B) M I D Ctarapur Industrial Area, Thane, Maharashtra, India – 401506.

As per the financials filed for FY 2025, the company reported a revenue of ₹168.31 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹10.44 Cr (net margin 6.2%) and EBITDA of ₹15.78 Cr (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 6% over five years.

The company has about 739 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Group Pharma and Group Pharmaceuticals Ltd. As per MCA filings, the company has open charges of ₹20 Cr and satisfied charges of ₹31.62 Cr on record. Court records list 53 cases involving the company, including 33 filed by the company and 20 filed against it; 5 cases are pending. The company has 3 deals on record (2 acquisitions, 1 rights issue); the latest was in September 2026. Its 5 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Shree Krishnakeshav Laboratories Limited with revenue of ₹170.52 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 367 overdue payments to 44 micro and small suppliers.

Group Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0014465). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website grouppharma.in.

Company details

CIN U24239MH1980PLC022889
Registration Number 022889
Incorporation Date 24 July 1980
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 July 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0014465

CIN history

Group Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239MH1980PTC022889. The current CIN is U24239MH1980PLC022889, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239MH1980PLC022889Current
U24239MH1980PTC022889Previous
Key People
Deepak Mohan Managing Director Ann Valerie Sunil Attavar Whole-Time Director Sunil Attavar Cajaten Nodal Officer

Recognitions & Rankings of Group Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-18-0014465

Contact details

Group Pharmaceuticals Limited's registered office is in Thane, Maharashtra. Its website is grouppharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    grouppharma.in
  • Social Media
  • Registered Address
    W – 46 (B) M I D Ctarapur Industrial Area, Thane, Maharashtra, India – 401506
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Group Pharmaceuticals Limited, buy the company report.

Comprehensive company report
Group Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Group Pharmaceuticals operates two associated brands: Group Pharma and Group Pharmaceuticals Ltd. Each brand links to its own profile.

BrandDescriptionWebsite
Group Pharma
Manufactures specialized oral care and healthcare products for consumers and partners worldwide.grouppharma.com
Group Pharmaceuticals Ltd
Oral care and healthcare product manufacturing and exporting.grouppharma.in

Business activity

The main business activity of Group Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Group Pharmaceuticals Limited, buy the company report.

Financials of Group Pharmaceuticals Limited

FY 2025 filings available

Group Pharmaceuticals Limited reported revenue of ₹168.31 Cr (up 10% YoY) for FY 2025.

Revenue · FY 2025
₹168.31 Cr ▲ 10%
Net profit · FY 2025
₹10.44 Cr margin 6.2%
EBITDA · FY 2025
₹15.78 Cr margin 9.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 9%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 21%
5 years · compounded
▲ 12%

Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 10% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹15.78 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹10.44 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.4%
Net Profit Margin6.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Group Pharmaceuticals Limited, buy the company report.

Board of directors of Group Pharmaceuticals Limited

Group Pharmaceuticals has 7 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Deepak Mohan
Also directs: Mape Pharmascience LLP, Vinimaya Advisory LLP, Vyapaka Advisory LLP and 4 more
Managing Director24 May 20242 Years 5 MonthsCurrent
Sunil Attavar Cajaten
Also directs: Engaged Professional Service Private Limited, Secure Dentalreach Private Limited
Nodal Officer17 Sep 20197 Years 1 MonthsCurrent
Ann Valerie Sunil Attavar
Also directs: Secure Dentalreach Private Limited, Sugam Laboratories Private Limited
Whole-Time Director15 Sep 200818 Years 1 MonthsCurrent
Srinivas GogineniDirector08 Aug 20242 Years 2 MonthsCurrent
Nandipur Kallappa DilipDirector08 Aug 20242 Years 2 MonthsCurrent
Jacob Mathew
Also directs: Mape Citrus Developers LLP, Jacob Mathew Family Office LLP, Mape Pharmascience LLP and 5 more
Director24 May 20242 Years 5 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Peer comparison

Group Pharmaceuticals Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Shree Krishnakeshav Laboratories Limited₹170.52 Cr (FY 2025)13.0%Ahmedabad, Gujarat, India
Stericon Pharma Private Limited₹169.15 Cr (FY 2025)21.0%Bangalore, Karnataka, India
Eurolife Healthcare Private Limited₹168.9 Cr (FY 2020)-20.0%Thane, Maharashtra, India
Group Pharmaceuticals Limitedthis company₹168.31 Cr (FY 2025)₹10.44 Cr6.2%10.0%739Thane, Maharashtra, India
DWD Pharmaceuticals Limited₹166.47 Cr (FY 2025)10.0%Mumbai, Maharashtra, India
Srini Pharmaceuticals Private Limited₹165.56 Cr (FY 2024)-18.0%Hyderabad, Telangana, India

To see the full peer comparison of Group Pharmaceuticals Limited, buy the company report.

Auditor

Group Pharmaceuticals Limited is audited by G. K. Gadgil & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
G. K. Gadgil & Co.FY 2024102879W

Shareholding

The shareholding of Group Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Group Pharmaceuticals Limited, buy the company report.

Charges & borrowings

Open charges
₹20 Cr
Satisfied charges
₹31.62 Cr
Breakdown by lending institutions
Others₹20.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Oct 2025101182496Others₹20 CrOpen
04 Mar 200590145693Others₹16.25 CrSatisfied
27 Mar 200290143823Central Bank of India₹5.5 CrSatisfied
04 Aug 200190143516Central Bank of India₹-Satisfied
12 Jul 199990142465Central Bank of India₹-Satisfied

To see the full charge records of Group Pharmaceuticals Limited, buy the company report.

Total charge records: 18 View all charges

Deals & funding

Group Pharmaceuticals Limited has 3 deals on record (2 acquisitions, 1 rights issue); the latest was in September 2026.

Total deals
3
Acquisitions
2
Rights issue
1

Deals on record (3 of 3)

WhenDealAmountParties
Sep 2026Acquisition₹23.7 CrBuyer: Jagson Pal Pharmaceuticals Limited.
Seller: Group Pharmaceuticals Limited
Sep 2025Rights issue₹10.15 CrInvestors: MAPE Group, Others - Group Pharmaceuticals Limited, 2 individuals
Jan 2002Acquisition₹28.79 CrBuyer: Dr.Reddy's Laboratories Ltd
Seller: Group Pharmaceuticals Limited

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Group Pharmaceuticals Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 367 overdue payments to 44 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 44)

SupplierAmount dueDue sinceReported on
Diamond Corporation
an individual supplier
Armor Plast Private Limited
an individual supplier
Teamlease Regtech Private Limited

To see the full MSME payment records of Group Pharmaceuticals Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Group Pharmaceuticals Limited has a workforce of 739 employees on its EPFO records as of Mar 08, 2025, across 1 active EPFO establishment.

Employee count
739
Active EPFO establishments
1
Employee growth
9.97%

GST

Group Pharmaceuticals has 12 GST registrations: 2 active and 10 cancelled or inactive.

Total GSTINs
12
Active
2
Cancelled / inactive
10
GSTINStateStatusRegistered on
27AAACG8723H1ZKMaharashtraActive01 Jul 2017
29AAACG8723H1ZGKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Group Pharmaceuticals Limited, buy the company report.

Recent activity

Group Pharmaceuticals Limited has 25 board changes on record since 2008: 9 appointments and 16 cessations. The latest: Nikhil Kaushik was appointed as Additional Director on 29 Sep 2025.

Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101182496 was registered on 28 Oct 2025.
Appointed
Nikhil Kaushik was appointed as Additional Director.
AGM
Group Pharmaceuticals Limited last Annual general meeting of members was held on 26 Jul 2025 as per latest MCA records.
Appointed
Nikhil Kaushik was appointed as CEO.
Filing
Group Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Annasagaram Balagurunath Ramkumar ceased to be Additional Director.
Ceased
Jacob Mathew ceased to be Additional Director.
Ceased
Nandipur Kallappa Dilip ceased to be Additional Director.
Ceased
Srinivas Gogineni ceased to be Additional Director.
Appointed
Annasagaram Balagurunath Ramkumar was appointed as Whole-Time Director.
Appointed
Nandipur Kallappa Dilip was appointed as Director.
Appointed
Srinivas Gogineni was appointed as Director.

58 earlier events are in the company report.

News

Frequently asked questions

Group Pharmaceuticals is an active public limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 July 1980 (46+ years old) and is registered under CIN U24239MH1980PLC022889.

Group Pharmaceuticals has 7 current directors:

The latest financial statements of Group Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 July 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Group Pharmaceuticals is 27AAACG8723H1ZK, registered in Maharashtra. The company has 12 GST registrations in all, of which 2 are active and 10 are cancelled or inactive. Other active GSTINs include 29AAACG8723H1ZG (Karnataka).

The CIN (Corporate Identification Number) of Group Pharmaceuticals is U24239MH1980PLC022889. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Group Pharmaceuticals has 53 court cases on record: 33 filed by the company and 20 filed against it. 5 are pending. Most are in the high courts.

Group Pharmaceuticals was incorporated on 24 July 1980, making it 46+ years old. It is registered with the Registrar of Companies, Mumbai.

Group Pharmaceuticals has 3 deals on record (2 acquisitions, 1 rights issue); the latest was in September 2026.

The peers of Group Pharmaceuticals by revenue are Shree Krishnakeshav Laboratories Limited, Stericon Pharma Private Limited, Eurolife Healthcare Private Limited, DWD Pharmaceuticals Limited, Srini Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Nikhil Kaushik was appointed as Additional Director on 29 Sep 2025. Nikhil Kaushik was appointed as CEO on 12 May 2025. Annasagaram Balagurunath Ramkumar ceased to be Additional Director on 20 Sep 2024. Group Pharmaceuticals has 25 board changes on record in total.

Yes, Group Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0014465).

Group Pharmaceuticals has 14 MSME Form 1 returns on record between 2019 and 2024, listing 367 overdue payments to 44 micro and small suppliers. The latest return was filed on 30 Apr 2024.